UA99621U - Способ лечения хронического билиарного панкреатита - Google Patents
Способ лечения хронического билиарного панкреатитаInfo
- Publication number
- UA99621U UA99621U UAU201500488U UAU201500488U UA99621U UA 99621 U UA99621 U UA 99621U UA U201500488 U UAU201500488 U UA U201500488U UA U201500488 U UAU201500488 U UA U201500488U UA 99621 U UA99621 U UA 99621U
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- dose
- chronic biliary
- antispasmodic
- biliary pancreatitis
- Prior art date
Links
- 206010033645 Pancreatitis Diseases 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 108010067035 Pancrelipase Proteins 0.000 abstract 1
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 1
- 229940124575 antispasmodic agent Drugs 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 229940080133 omeprazole 20 mg Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Способ лечения хронического билиарного панкреатита путем перорального приема препаратов базисного лечебного комплекса в составе ферментного препарата Креон в дозе 10000-40000 ЕД трижды в день в зависимости от тяжести ферментативной недостаточности, антисекреторного препарата на основе омепразола в дозе 20 мг два раза в сутки и спазмолитического средства. В качестве спазмолитического средства назначают Магне В6 в дозе 10 мл перорально три раза в сутки во время приема пищи, причем курс лечения продолжают 20 дней.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201500488U UA99621U (ru) | 2015-01-22 | 2015-01-22 | Способ лечения хронического билиарного панкреатита |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201500488U UA99621U (ru) | 2015-01-22 | 2015-01-22 | Способ лечения хронического билиарного панкреатита |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99621U true UA99621U (ru) | 2015-06-10 |
Family
ID=53675645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201500488U UA99621U (ru) | 2015-01-22 | 2015-01-22 | Способ лечения хронического билиарного панкреатита |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA99621U (ru) |
-
2015
- 2015-01-22 UA UAU201500488U patent/UA99621U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021002321A (es) | Nuevos metodos. | |
| MY199968A (en) | Formulations of an lsd1 inhibitor | |
| PH12016501394A1 (en) | Compounds for treating patients with ros1 mutant cancer cells | |
| MX360045B (es) | Combinaciones farmacéuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf. | |
| WO2016133903A3 (en) | Combination therapy for cancer treatment | |
| MY199967A (en) | Combinations of lsd1 inhibitors for use in the treatment of solid tumors | |
| MX2014010590A (es) | Terapia de combinacion para trastornos proliferativos. | |
| PH12016502103A1 (en) | Novel disubstituted 1,2, 4-triazine compound | |
| PH12014500386A1 (en) | Combination treatment for hepatitis c | |
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| ZA202301198B (en) | Method of treating diseases | |
| MX2012013879A (es) | Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas. | |
| AU2018282105A1 (en) | Dosing of vibegron for treatment of overactive bladder | |
| ZA202000028B (en) | Use of vibegron to treat overactive bladder | |
| CA2902116C (en) | Pyrrolopyridine derivatives and their use as inhibitors of ssao activity | |
| MX2015013155A (es) | Formulaciones farmaceuticas de la familia de la tetrandrina y metodo. | |
| UA115250C2 (uk) | Фармацевтичні комбінації | |
| PH12022553376A1 (en) | Acalabrutinib maleate dosage forms | |
| WO2020243273A3 (en) | Methods of treating cholangiocarcinoma | |
| MX2022006052A (es) | Inhibidores de la caspasa 6 y usos de los mismos. | |
| TW200800977A (en) | A new salt | |
| MY187270A (en) | Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor | |
| UA99621U (ru) | Способ лечения хронического билиарного панкреатита | |
| TW201613600A (en) | Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically | |
| MX2020001217A (es) | Metodos de tratamiento de sintomas de gastroparesia usando velusetrag. |